These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9228992)

  • 1. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Massel D
    Lancet; 1997 Jul; 350(9071):147. PubMed ID: 9228992
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Girbes AR; Zijlstra JG
    Lancet; 1997 Jul; 350(9071):147-8. PubMed ID: 9228993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk factors for dying among ibopamine users].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for dying among ibopamine users].
    de Graeff PA; Elferink AJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 May; 143(21):1114-5. PubMed ID: 10368748
    [No Abstract]   [Full Text] [Related]  

  • 7. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Ferrari V; Sher D; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
    Sher D; Licciardello L; Ferrari V; Sirtori F; Cesana B
    Arzneimittelforschung; 1991 Apr; 41(4):402-9. PubMed ID: 1859514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study on the clinical efficacy of chronic ibopamine administration.
    Dei Cas L; Barilli AC; Metra M; Fracalossi C; Lomanto B; Santambrogio S; Pinca L; Longhini C; Cavicchi E; Maggi GC
    Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug of the month. Ibopamine (Scandine, Idopamil)].
    Scheen AJ
    Rev Med Liege; 1994 Jun; 49(6):365-6. PubMed ID: 8047755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ibopamine--clinical results].
    Kleber FX
    Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
    Sher D; Ferrari V
    Arzneimittelforschung; 1987 Jul; 37(7A):873-900. PubMed ID: 3675684
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
    Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
    Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
    Kleber FX; Thyroff-Friesinger U
    Z Kardiol; 1991; 80 Suppl 8():113. PubMed ID: 1796629
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):897-902. PubMed ID: 2487550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
    Holubarsch C; Just H
    Cardiology; 1990; 77 Suppl 5():1-8. PubMed ID: 2279251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.